Somnigroup International
SGI · NYSEHousehold Furniture · Fiscal year ends Dec 31
Somnigroup International reported revenue of $7.5B in the fiscal year ended Dec 2025, up 51.6% from the year before. Operating income was $755M, an operating margin of 10.1%, and net income was $384M. Operating cash flow of $800M less capital expenditure of $167M left free cash flow of $633M. Net debt was $4.5B.
Last 5 fiscal years
Revenue and net income
Income statement
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | $4.9B | $4.9B | $4.9B | $4.9B | $7.5B |
| Cost of revenue | $2.8B | $2.9B | $2.9B | $2.9B | $4.3B |
| Gross profit | $2.2B | $2B | $2B | $2B | $3.2B |
| Research & development | $27M | $29M | $31M | $31M | $33M |
| Operating income | $912M | $681M | $607M | $634M | $755M |
| Interest expense | $66M | $103M | $130M | $135M | $268M |
| Pre-tax income | $824M | $577M | $474M | $504M | $481M |
| Income tax | $198M | $119M | $103M | $119M | $96M |
| Net income | $625M | $456M | $368M | $384M | $384M |
| Diluted EPS | 3.06 | 2.53 | 2.08 | 2.16 | 1.84 |
| Diluted shares | 204M | 180M | 177M | 178M | 209M |
Balance sheet
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $301M | $69M | $75M | $1.7B | $135M |
| Receivables | $420M | $423M | $431M | $405M | $359M |
| Inventory | $464M | $555M | $483M | $447M | $630M |
| Current assets | $1.3B | $1.2B | $1.1B | $1.1B | $1.3B |
| Goodwill | $1.1B | $1.1B | $1.1B | $1.1B | $4.6B |
| Total assets | $4.3B | $4.4B | $4.6B | $6B | $11.6B |
| Payables | $432M | $360M | $311M | $361M | $402M |
| Deferred revenue | $52M | $49M | $53M | $59M | $105M |
| Current liabilities | $1.1B | $981M | $908M | $960M | $1.6B |
| Long-term debt | $2.3B | $2.8B | $2.5B | $3.8B | $4.6B |
| Total liabilities | $4B | $4.4B | $4.2B | $5.4B | $8.5B |
| Shareholders' equity | $286M | −$22M | $323M | $559M | $3.1B |
Cash flow
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $723M | $379M | $570M | $667M | $800M |
| Capital expenditure | $123M | $307M | $185M | $97M | $167M |
| Free cash flow | $600M | $72M | $385M | $569M | $633M |
| Depreciation & amortisation | $175M | $180M | $183M | $202M | $291M |
| Stock-based compensation | $61M | $53M | $48M | $36M | $41M |
| Acquisitions | $433M | $0 | $3M | $0 | $2.8B |
| Dividends paid | $63M | $71M | $78M | $93M | $127M |
| Dividend per share | 0.32 | 0.40 | 0.44 | 0.52 | 0.60 |
Key ratios
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | −0.2% | 0.1% | 0.1% | 51.6% |
| Operating income growth (YoY) | – | −25.4% | −10.8% | 4.4% | 19.0% |
| EPS growth (YoY) | – | −17.3% | −17.8% | 3.8% | −14.8% |
| Gross margin | 43.8% | 41.6% | 40.3% | 41.1% | 42.6% |
| Operating margin | 18.5% | 13.8% | 12.3% | 12.9% | 10.1% |
| Net margin | 12.7% | 9.3% | 7.5% | 7.8% | 5.1% |
| Return on equityBlank when equity is negative | 218.5% | – | 113.8% | 68.7% | 12.4% |
| ROCEEBIT ÷ (assets − current liabilities) | 27.9% | 20.1% | 16.7% | 12.6% | 7.5% |
| Free cash flow margin | 12.2% | 1.5% | 7.8% | 11.5% | 8.5% |
| Cash conversion (CFO ÷ net income) | 1.16x | 0.83x | 1.55x | 1.73x | 2.08x |
| Receivable days | 31 | 31 | 32 | 30 | 18 |
| Inventory days | 61 | 71 | 60 | 56 | 54 |
| Payable days | 57 | 46 | 39 | 45 | 34 |
| Interest cover | 13.8x | 6.61x | 4.67x | 4.70x | 2.82x |
| Debt ÷ equity | 7.97x | – | 7.74x | 6.72x | 1.48x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | $2B | $2.7B | $2.4B | $2B | $4.5B |
| Current ratio | 1.21x | 1.22x | 1.21x | 1.11x | 0.83x |
Recent filings
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.